首页 正文

Immune checkpoint inhibitors and myocarditis-myositis-myasthenia gravis overlap: a FAERS pharmacovigilance study with time-to-onset characterization

{{output}}
Background: Immune checkpoint inhibitors (ICIs) are associated with rare but life-threatening immune-related adverse events. Myocarditis-myositis-myasthenia gravis (MMM) overlap is among the most severe neuromuscular-cardiac toxi... ...